middl
east
respiratori
syndrom
mer
emerg
saudi
arabia
death
man
pneumonia
caus
agent
subsequ
identifi
merscov
belong
lineag
c
betacoronavirus
dromedari
camel
camelu
dromedariu
also
known
arabian
camel
direct
sourc
bat
potenti
reservoir
merscov
frequent
introduc
human
popul
merscov
introduc
person
persontoperson
transmiss
might
occur
respons
approxim
mer
case
global
merscov
consist
threat
human
octob
merscov
caus
laboratoryconfirm
human
case
includ
death
countri
fatal
rate
high
http
wwwwhointemergenciesmerscoven
although
mer
case
primarili
report
middl
east
facilit
intern
travel
merscov
also
worldwid
threat
well
illustr
mer
outbreak
south
korea
given
potenti
risk
caus
worldwid
public
health
emerg
absenc
licens
vaccin
antivir
therapeut
world
health
organ
list
merscov
list
blueprint
prioriti
diseas
http
wwwwhointblueprintprioritydiseasesen
vaccin
import
approach
viral
infect
usual
take
long
time
develop
also
unabl
provid
either
immedi
prophylact
protect
treat
ongo
viral
infect
neutral
monoclon
antibodi
mab
recent
emerg
power
tool
provid
prophylact
therapeut
protect
emerg
virus
potent
neutral
mab
achiev
variou
technolog
hybridoma
technolog
human
mous
phage
yeast
display
singl
b
cell
isol
merscov
singl
positivestrand
rna
viru
kb
encod
four
major
viral
structur
spike
envelop
e
membran
nucleocapsid
n
well
sever
accessori
protein
protein
aa
play
import
role
viru
infect
consist
receptorbind
subunit
aa
membranefus
subunit
aa
mediat
viral
attach
host
cell
mediat
viruscel
membran
fusion
subunit
contain
receptorbind
domain
rbd
aa
bind
cell
receptor
dipeptidyl
peptidas
also
known
mediat
viral
attach
target
cell
rbd
consist
core
subdomain
receptorbind
motif
rbm
aa
schemat
represent
merscov
protein
shown
figur
neutral
mab
bind
protein
merscov
prevent
viral
attach
cell
receptor
inhibit
viral
entri
protein
merscov
key
target
antivir
rbd
popular
focu
studi
review
current
knowledg
neutral
mab
target
rbd
merscov
stabl
hybridoma
cell
line
gener
fuse
myeloma
cell
splenocyt
mice
immun
mersrbd
protein
two
neutral
mab
high
affin
rbd
merscov
block
pseudoviru
live
merscov
entri
cell
high
efficaci
human
show
similar
neutral
activ
cell
entri
test
vivo
test
indic
could
significantli
reduc
viru
titer
lung
mice
infect
merscov
highlight
potenti
applic
human
prevent
also
treat
merscov
infect
crystal
fabmersrbd
complex
show
recogn
conform
epitop
partial
overlap
receptorbind
footprint
rbd
merscov
complex
interf
merscov
bind
steric
hindranc
interfaceresidu
competit
compet
bind
mersrbd
indic
recogn
proxim
overlap
epitop
neutral
mab
obtain
fuse
myeloma
cell
splenocyt
mous
immun
recombin
merscov
effect
block
entri
pseudoviru
live
merscov
cell
structur
analysi
show
bound
rbd
merscov
recogn
conform
epitop
residu
critic
bind
locat
left
ridg
rbm
neutral
merscov
competit
block
bind
merscov
rbd
base
escap
mutant
analysi
key
residu
rbd
found
residu
critic
bind
rbd
mutat
affect
interact
rbd
ultralarg
nonimmun
human
antibodyphag
display
librari
construct
b
cell
unimmun
donor
uniqu
span
strategi
seven
human
neutral
mab
vari
neutral
efficaci
merscov
identifi
bind
detect
demonstr
epitop
mab
lay
within
aa
protein
overlap
larg
part
rbd
merscov
bind
competit
assay
show
mab
recogn
least
three
distinct
epitop
group
confirm
escap
studi
crossepitop
resist
mab
neutral
merscov
competit
block
bind
rbd
merscov
escap
mutant
assay
show
five
residu
critic
neutral
mab
name
seven
mab
exhibit
best
neutral
activ
pseudoviru
live
merscov
infect
cell
moreov
select
pressur
mab
igg
form
superior
sinc
induc
neutral
escap
vivo
test
demonstr
reduc
lung
patholog
rhesu
monkey
infect
merscov
high
neutral
activ
suppress
mutant
escap
igg
form
promis
therapeut
mab
merscov
three
human
identifi
larg
human
phage
display
antibodi
librari
construct
peripher
blood
mononuclear
cell
healthi
volunt
bind
sti
three
mab
within
rbd
merscov
aa
therefor
neutral
merscov
compet
bind
rbd
three
mab
also
compet
bind
rbd
merscov
mutant
analysi
show
three
mab
possess
overlap
distinct
epitop
three
mab
neutral
pseudoviru
live
merscov
infect
cell
except
potenc
inhibit
merscov
pseudoviru
infect
concentr
gml
neutral
live
merscov
gml
gml
residu
rbd
crucial
bind
vivo
studi
demonstr
prophylaxi
reduc
viru
titer
lung
rabbit
infect
merscov
also
provid
transgen
mice
express
human
full
prophylact
therapeut
protect
merscov
howev
anoth
studi
nonhuman
primat
common
marmoset
show
could
allevi
sever
diseas
provid
complet
protect
merscov
igg
memori
b
cell
isol
mer
patient
subsequ
immort
viru
neutral
mab
identifi
first
fulli
human
neutral
mab
heavi
light
chain
pair
effici
neutral
merscov
infect
cell
vivo
studi
show
provid
balbc
mice
transduc
adenovir
vector
express
human
prophylact
postexposur
protect
merscov
furthermor
neutral
efficaci
evalu
receptorknockout
mice
stringent
model
merscov
infect
transduc
mice
show
profound
clinic
symptom
challeng
merscov
administr
reduc
merscov
titer
lung
mice
effect
lung
viral
titer
reduc
three
log
one
day
receptorknockout
mice
vs
three
day
balbc
mice
heavi
light
chain
pair
potent
compar
crosscompetit
experi
demonstr
compet
bind
rbd
interact
rbd
residu
around
footprint
rbd
partial
overlap
four
residu
rbd
affect
bind
conserv
merscov
isol
moreov
compar
bind
affin
rbd
significantli
higher
therefor
one
major
neutral
mechan
competit
inhibit
interact
rbd
interestingli
viru
escap
studi
demonstr
select
pressur
mutant
variant
ntermin
domain
ntd
merscov
subunit
also
gener
gmpapprov
cell
line
express
high
concentr
establish
highlight
applic
promis
therapeut
merscov
infect
hybridoma
b
cell
produc
neutral
mab
protein
merscov
gener
immun
human
transgen
mice
velocimmun
mice
dna
encod
merscov
protein
two
fulli
human
neutral
mab
obtain
two
mab
bound
high
affin
distinct
epitop
rbd
merscov
conserv
natur
evolut
merscov
mutat
result
select
pressur
one
mab
affect
bind
mab
neutral
broad
rang
merscov
isol
prototyp
strain
clinic
mutant
includ
except
variant
achiev
similar
neutral
activ
vivo
studi
demonstr
reduc
merscov
replic
human
mice
prophylact
therapeut
set
evalu
common
marmoset
mab
seem
effect
prophylaxi
rather
treatment
merscov
infect
antimerscov
phage
display
antibodi
librari
construct
peripher
b
cell
mer
survivor
human
neutral
mab
merscov
identifi
show
potent
neutral
activ
merscov
cell
entri
test
vivo
complet
inhibit
replic
merscov
common
marmoset
administr
prophylact
therapeut
structur
analysi
fabrbd
complex
show
form
direct
contact
receptorbind
site
rb
subdomain
rbd
epitop
rb
critic
bind
superimpos
structur
analysi
complex
show
bind
interfac
larg
overlap
therefor
neutral
mechan
achiev
compet
bind
rbd
two
potent
human
neutral
mab
deriv
nonimmun
human
yeast
display
antibodi
librari
construct
spleen
lymph
node
polyadenyl
rna
normal
human
inhibit
entri
pseudoviru
live
merscov
cell
mutant
analysi
suggest
recogn
distinct
epitop
rbd
merscov
epitop
might
locat
away
recogn
mutant
analysi
also
demonstr
residu
rbd
critic
bind
import
bind
combin
use
demonstr
synergist
effect
pseudotyp
merscov
bound
rbd
higher
affin
primari
neutral
mechan
block
bind
rbd
structur
analysi
show
bound
uniqu
epitop
caus
conform
chang
rbd
interfac
critic
accommod
therefor
indirectli
disrupt
interact
two
moreov
also
demonstr
synergist
effect
ntdspecif
mab
special
neutral
mechan
made
valuabl
addit
combin
use
mab
merscov
infect
thirteen
ultrapot
neutral
mab
target
rbd
merscov
gener
follow
protocol
rapid
product
antigenspecif
human
mab
briefli
antibodysecret
b
cell
isol
whole
blood
mer
patient
antibodi
gene
amplifi
clone
vector
transfect
human
cell
line
mab
product
mab
exhibit
strongest
neutral
activ
pseudoviru
live
merscov
cell
infect
test
directli
compet
bind
rbd
crystal
structur
show
epitop
almost
complet
overlap
site
recogn
distinct
epitop
rbd
low
level
compet
activ
combin
use
two
mab
demonstr
synergist
effect
neutral
pseudotyp
merscov
mutant
analysi
demonstr
residu
rbd
import
neutral
activ
residu
critic
moreov
vivo
studi
found
could
provid
prophylact
therapeut
protect
mice
merscov
infect
vhh
complementari
dna
librari
construct
bone
marrow
dromedari
camel
infect
merscov
four
vhh
high
neutral
activ
identifi
direct
clone
screen
phage
display
antibodi
librari
four
vhh
compet
singl
epitop
partial
overlap
interfac
mutant
analysi
show
four
vhh
bind
variant
critic
residu
rbd
bind
therefor
vhh
like
neutral
merscov
block
bind
vhh
show
best
neutral
activ
epitop
recognit
effici
block
entri
merscov
cell
also
prophylact
protect
transgen
mous
express
merscov
infect
extend
halflif
serum
link
human
fc
domain
lack
exon
construct
chimer
camelhuman
show
similar
neutral
activ
chimer
camelhuman
highli
stabl
mice
provid
mice
fulli
prophylact
protect
merscov
infect
alpaca
immun
recombin
merscov
rbdcontain
ctermin
human
fc
tag
vhh
amplifi
peripher
blood
mononuclear
cell
construct
vhh
phage
display
librari
neutral
nb
bound
high
affin
rbd
merscov
block
bind
rbd
identifi
extend
vivo
halflif
humanfcfus
version
construct
compet
bind
rbd
indic
bind
site
rbd
overlap
bind
site
rbd
map
around
residu
part
highli
conserv
conform
epitop
receptorbind
interfac
almost
natur
merscov
publish
date
neutral
psuedotyp
merscov
bear
mutat
confirm
residu
critic
bind
effici
neutral
cell
entri
live
merscov
moreov
show
potent
prophylact
therapeut
efficaci
protect
mice
merscov
infect
except
high
neutral
activ
vitro
vivo
newli
identifi
neutral
mab
promis
candid
therapeut
infect
merscov
howev
use
singl
neutral
antibodi
bear
risk
select
escap
mutant
fact
observ
describ
antibodi
notabl
major
escap
mutat
littl
impact
viral
fit
interact
rbd
moreov
mutant
merscov
natur
infect
also
report
escap
neutral
major
concern
therapeut
neutral
mab
howev
potenti
problem
solv
combin
mab
target
distinct
epitop
show
differ
neutral
mechan
strategi
take
advantag
synergist
effect
decreas
possibl
viral
escap
current
merscov
neutral
mab
compet
bind
rbd
residu
rbd
critic
mab
neutral
identifi
mutant
analysi
almost
residu
identifi
critic
mab
neutral
locat
rbm
overlap
critic
bind
figur
avail
crystal
structur
mab
fabrbd
complex
neutral
mechan
mab
better
illustr
base
crystal
structur
found
sever
conserv
residu
rbd
critic
interact
rbd
develop
therapeut
neutral
mab
target
critic
conserv
residu
might
import
combat
merscov
moreov
studi
found
mousederiv
neutral
mab
bound
possibl
linear
epitop
ntd
merscov
subunit
exhibit
effici
neutral
activ
pseudoviru
live
merscov
cell
entri
test
studi
highlight
import
role
ntd
infect
process
merscov
ntd
might
signific
implic
develop
prophylact
therapeut
mab
merscov
infect
although
vitro
neutral
potenc
approxim
lower
rbdtarget
neutral
mab
may
provid
altern
immunotherapi
merscov
viru
mutat
longer
suscept
rbdspecif
mab
far
lack
appropri
anim
model
mimic
patholog
merdcov
human
commonlyus
laboratori
wildtyp
mous
ferret
hamster
guinea
suscept
merscov
infect
due
differ
critic
amino
acid
sbind
domain
new
zealand
rabbit
mice
camelid
nonhuman
primat
rhesu
macaqu
common
marmoset
suscept
merscov
infect
howev
rabbit
show
asymptomat
infect
dromedari
camel
display
differ
clinic
manifest
human
rhesu
macaqu
show
transient
lower
respiratori
infect
common
marmoset
develop
progress
pneumonia
mous
express
extens
result
multipl
organ
damag
mous
exhibit
mild
transient
clinic
diseas
robust
anim
model
protect
effect
neutral
mab
better
evalu
furthermor
ongo
effort
develop
therapeut
neutral
mab
merscov
also
consid
differ
target
popul
dromedari
camel
human
protect
efficaci
